Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Low-dose nivolumab leads to improved overall survival for head and neck cancer patients

Dr Bishal Gyawali - Queen's University, Kingston, Canada
Low-dose nivolumab leads to improved overall survival for head and neck cancer patients ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
19 Jul 2022

Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients

Dr Bishal Gyawali - Queen's University, Kingston, Canada
Palbociclib shows improved PFS but not improved OS for ER+ HER2- mBC patients ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
19 Jul 2022

Updates from the PROpel and MAGNITUDE studies

Prof Phil Cornford and Dr Elena Castro
Updates from the PROpel and MAGNITUDE studies ( Prof Phil Cornford and Dr Elena Castro )
11 Jul 2022

Update on the latest in PARP inhibitors for prostate cancer

Prof Axel Merseburger and Prof Bertrand Tombal
Update on the latest in PARP inhibitors for prostate cancer ( Prof Axel Merseburger and Prof Bertrand Tombal )
11 Jul 2022

Isatuximab + Pd in Difficult-to-Treat Patients with RRMM

Dr Maximilian Merz - Leipzig University, Leipzig, Germany
Isatuximab + Pd in Difficult-to-Treat Patients with RRMM ( Dr Maximilian Merz - Leipzig University, Leipzig, Germany )
11 Jul 2022

ASCO Direct Highlights 2022: prostate cancer highlights

Dr Chandler Park - Baptist Health Hardin, Elizabethtown, USA
ASCO Direct Highlights 2022: prostate cancer highlights ( Dr Chandler Park - Baptist Health Hardin, Elizabethtown, USA )
9 Jul 2022

ASCO Direct Highlights 2022: lung cancer highlights

Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA
ASCO Direct Highlights 2022: lung cancer highlights ( Dr Tom Stinchcombe - Duke Cancer Center, Durham, USA )
9 Jul 2022

Locally and advanced immunotherapy developments and new agents in lung cancer

Dr George Simon - Moffitt Advent Health Clinical Research Unit, Tampa, USA
Locally and advanced immunotherapy developments and new agents in lung cancer ( Dr George Simon - Moffitt Advent Health Clinical Research Unit, Tampa, USA )
9 Jul 2022

The advances in the management of patients with Hodgkin lymphoma and non-Hodgkin lymphoma

Dr Eduardo Sotomayor - H. Lee Moffitt Cancer Center & Research Institute, Florida, USA
The advances in the management of patients with Hodgkin lymphoma and non-Hodgkin lymphoma ( Dr Eduardo Sotomayor - H. Lee Moffitt Cancer Center & Research Institute, Florida, USA )
9 Jul 2022

Oncology Medical Homes

Dr Brian Bourbeau - American Society of Clinical Oncology (ASCO), Virgina, USA
Oncology Medical Homes ( Dr Brian Bourbeau - American Society of Clinical Oncology (ASCO), Virgina, USA )
9 Jul 2022

Diversity and inclusion in oncological care

Dr Vedner Guerrier - Memorial Healthcare System, Hollywood, USA
Diversity and inclusion in oncological care ( Dr Vedner Guerrier - Memorial Healthcare System, Hollywood, USA )
9 Jul 2022

New developments in the treatment of colorectal malignancies

Dr Richard Kim - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA
New developments in the treatment of colorectal malignancies ( Dr Richard Kim - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )
8 Jul 2022